Search

Anne Marie Falk

Examiner (ID: 427)

Most Active Art Unit
1632
Art Unit(s)
1632
Total Applications
685
Issued Applications
242
Pending Applications
153
Abandoned Applications
292

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7113444 [patent_doc_number] => 20050210536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Modulation of brain pathways and function' [patent_app_type] => utility [patent_app_number] => 11/005919 [patent_app_country] => US [patent_app_date] => 2004-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12974 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20050210536.pdf [firstpage_image] =>[orig_patent_app_number] => 11005919 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/005919
Modulation of brain pathways and function Dec 5, 2004 Abandoned
Array ( [id] => 5479661 [patent_doc_number] => 20090202618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases' [patent_app_type] => utility [patent_app_number] => 10/580176 [patent_app_country] => US [patent_app_date] => 2004-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13950 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202618.pdf [firstpage_image] =>[orig_patent_app_number] => 10580176 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/580176
Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases Nov 23, 2004 Abandoned
Array ( [id] => 6918140 [patent_doc_number] => 20050095701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'PNS cell lines and methods of use therefor' [patent_app_type] => utility [patent_app_number] => 10/985784 [patent_app_country] => US [patent_app_date] => 2004-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 13737 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20050095701.pdf [firstpage_image] =>[orig_patent_app_number] => 10985784 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/985784
PNS cell lines and methods of use therefor Nov 8, 2004 Abandoned
Array ( [id] => 5867400 [patent_doc_number] => 20060101532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Methods for the identification of compounds for the treatment of Alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 10/983422 [patent_app_country] => US [patent_app_date] => 2004-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12654 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20060101532.pdf [firstpage_image] =>[orig_patent_app_number] => 10983422 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/983422
Methods for the identification of compounds for the treatment of Alzheimer's disease Nov 7, 2004 Abandoned
Array ( [id] => 7047279 [patent_doc_number] => 20050251874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Mice lacking alpha 1G showing enhanced novelty-seeking and alcohol preference and therapeutic methods for mood disorders by modulating alpha 1G T-type calcium channels' [patent_app_type] => utility [patent_app_number] => 10/971976 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6533 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20050251874.pdf [firstpage_image] =>[orig_patent_app_number] => 10971976 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/971976
Mice lacking alpha 1G showing enhanced novelty-seeking and alcohol preference and therapeutic methods for mood disorders by modulating alpha 1G T-type calcium channels Oct 21, 2004 Abandoned
Array ( [id] => 6938546 [patent_doc_number] => 20050112109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Discovery, localization, harvest, and propagation of an FGF2 and BDNF-responsive population of neural and neuronal progenitor cells in the adult human forebrain' [patent_app_type] => utility [patent_app_number] => 10/969896 [patent_app_country] => US [patent_app_date] => 2004-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12403 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112109.pdf [firstpage_image] =>[orig_patent_app_number] => 10969896 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/969896
Discovery, localization, harvest, and propagation of an FGF2 and BDNF-responsive population of neural and neuronal progenitor cells in the adult human forebrain Oct 20, 2004 Abandoned
Array ( [id] => 4841878 [patent_doc_number] => 20080282364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Phosphodiesterase 9 Inhibition as Treatment for Obesity-Related Conditions' [patent_app_type] => utility [patent_app_number] => 10/577700 [patent_app_country] => US [patent_app_date] => 2004-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17050 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20080282364.pdf [firstpage_image] =>[orig_patent_app_number] => 10577700 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/577700
Phosphodiesterase 9 Inhibition as Treatment for Obesity-Related Conditions Oct 17, 2004 Abandoned
Array ( [id] => 7050790 [patent_doc_number] => 20050186677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Novel mutated mammalian cells and animals' [patent_app_type] => utility [patent_app_number] => 10/964549 [patent_app_country] => US [patent_app_date] => 2004-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 5060 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20050186677.pdf [firstpage_image] =>[orig_patent_app_number] => 10964549 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/964549
Novel mutated mammalian cells and animals Oct 12, 2004 Abandoned
Array ( [id] => 5351922 [patent_doc_number] => 20090007283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'Transgenic Rodents Selectively Expressing Human B1 Bradykinin Receptor Protein' [patent_app_type] => utility [patent_app_number] => 10/573926 [patent_app_country] => US [patent_app_date] => 2004-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13187 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0007/20090007283.pdf [firstpage_image] =>[orig_patent_app_number] => 10573926 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/573926
Transgenic Rodents Selectively Expressing Human B1 Bradykinin Receptor Protein Oct 3, 2004 Abandoned
Array ( [id] => 9112889 [patent_doc_number] => 08569058 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Nerve regeneration promoters' [patent_app_type] => utility [patent_app_number] => 10/574479 [patent_app_country] => US [patent_app_date] => 2004-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14131 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10574479 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/574479
Nerve regeneration promoters Sep 30, 2004 Issued
Array ( [id] => 7235270 [patent_doc_number] => 20050262578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Non-human animal models of atherosclerosis and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/956790 [patent_app_country] => US [patent_app_date] => 2004-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19304 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20050262578.pdf [firstpage_image] =>[orig_patent_app_number] => 10956790 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/956790
Non-human animal models of atherosclerosis and methods of use thereof Sep 30, 2004 Abandoned
Array ( [id] => 6996227 [patent_doc_number] => 20050136005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Methods for modulation of cholesterol transport' [patent_app_type] => utility [patent_app_number] => 10/933037 [patent_app_country] => US [patent_app_date] => 2004-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10292 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20050136005.pdf [firstpage_image] =>[orig_patent_app_number] => 10933037 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/933037
Methods for modulation of cholesterol transport Sep 1, 2004 Abandoned
Array ( [id] => 4771375 [patent_doc_number] => 20080057033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Neural Stem Cells and Methods of Generating and Utilizing Same' [patent_app_type] => utility [patent_app_number] => 10/559929 [patent_app_country] => US [patent_app_date] => 2004-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10096 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057033.pdf [firstpage_image] =>[orig_patent_app_number] => 10559929 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/559929
Neural Stem Cells and Methods of Generating and Utilizing Same Jun 8, 2004 Abandoned
Array ( [id] => 7597636 [patent_doc_number] => 07618941 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-17 [patent_title] => 'Treating degenerative joint disorders with tribonectins' [patent_app_type] => utility [patent_app_number] => 10/858595 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9656 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/618/07618941.pdf [firstpage_image] =>[orig_patent_app_number] => 10858595 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/858595
Treating degenerative joint disorders with tribonectins May 31, 2004 Issued
Array ( [id] => 7199594 [patent_doc_number] => 20040205833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Human disease modeling using somatic gene transfer' [patent_app_type] => new [patent_app_number] => 10/477167 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13882 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20040205833.pdf [firstpage_image] =>[orig_patent_app_number] => 10477167 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/477167
Human disease modeling using somatic gene transfer May 31, 2004 Abandoned
Array ( [id] => 7247302 [patent_doc_number] => 20050081257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Method of producing non-human mammals' [patent_app_type] => utility [patent_app_number] => 10/850344 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7278 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20050081257.pdf [firstpage_image] =>[orig_patent_app_number] => 10850344 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/850344
Method of producing non-human mammals May 18, 2004 Abandoned
Array ( [id] => 7199623 [patent_doc_number] => 20040205838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Use of Flp recombinase in mice' [patent_app_type] => new [patent_app_number] => 10/846700 [patent_app_country] => US [patent_app_date] => 2004-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12889 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20040205838.pdf [firstpage_image] =>[orig_patent_app_number] => 10846700 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/846700
Use of Flp recombinase in mice May 16, 2004 Abandoned
Array ( [id] => 7060546 [patent_doc_number] => 20050002906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Gene therapy using replication competent targeted adenoviral vectors' [patent_app_type] => utility [patent_app_number] => 10/845489 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6387 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20050002906.pdf [firstpage_image] =>[orig_patent_app_number] => 10845489 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/845489
Gene therapy using replication competent targeted adenoviral vectors May 11, 2004 Abandoned
Array ( [id] => 7077713 [patent_doc_number] => 20050149994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Rapidly maturing fluorescent proteins and methods for using the same' [patent_app_type] => utility [patent_app_number] => 10/844064 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21270 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20050149994.pdf [firstpage_image] =>[orig_patent_app_number] => 10844064 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/844064
Rapidly maturing fluorescent proteins and methods for using the same May 10, 2004 Issued
Array ( [id] => 7428682 [patent_doc_number] => 20040209369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Controlling gene expression in living cells' [patent_app_type] => new [patent_app_number] => 10/838951 [patent_app_country] => US [patent_app_date] => 2004-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5491 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209369.pdf [firstpage_image] =>[orig_patent_app_number] => 10838951 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/838951
Controlling gene expression in living cells May 2, 2004 Abandoned
Menu